PERSPECTA

News from every angle

Back to headlines

Bristol-Myers Squibb Stock Rises on $400 Billion Reason

Bristol-Myers Squibb (BMY) stock saw an increase today, attributed to a significant $400 billion factor influencing its market performance.

3 Aug, 20:54 — 3 Aug, 20:54
PostShare

Sources

Showing 1 of 1 sources